Abstract

The following abstracts are those that were presented at the research competition of the Student Medical Summit held in University College Dublin on the 3rd February 2018. For more information about the Student Medical Summit visit www.studentmedicalsummit.org or contact info@studentmedicalsummit.org.

Highlights

  • Myotonic dystrophy (DM) is a multisystem autosomal dominant disorder

  • Collectively, the significant increase in acellular capillaries and the trend towards a decrease in pericyte numbers suggests a possible link between TRPV2 downregulation and vascular pathology associated with diabetic retinopathy

  • The results demonstrate that most studies yielded positive outcomes that suggest the effectiveness of art therapy, this was with small sample sizes

Read more

Summary

Introduction

Myotonic dystrophy (DM) is a multisystem autosomal dominant disorder. Gastrointestinal involvement is common with IBS-like symptoms often seen. Of patients initially presenting with stroke, 37.5% of the antiplatelet group progressed to full recovery compared to 100% of those on anticoagulation and 57.1 % on combined therapy (p=0.230). Conclusion: Our studies suggest that intracellular cytokine TNF- α production increase when stimulated with bacterial TLR ligands compare to baseline and patients infused with Infliximab have very low intracellular monocyte TNF- α which makes it a good target for treating patients with IBD. Conclusion: Vitrectomy rates were higher in the three years following the commencement of the DRS, the majority of which were for patients who had yet to engage with this service. It may be a number of years yet before increased screening uptake with DRS results in a reduction in vitrectomy rates. Conclusions: We recommend the incorporation of the Junior MARSIPAN guidelines into paediatric training programmes to potentially improve clinical diagnosis and management of underweight children

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call